Moody Aldrich Partners LLC reduced its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 2.2% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,341 shares of the pharmaceutical company’s stock after selling 52 shares during the period. Moody Aldrich Partners LLC’s […]